Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion type Assertion NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_head.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion evidence source_evidence_curated NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion SIO_000772 17295095 NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion wasDerivedFrom ctd_human-20130708 NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion wasGeneratedBy ECO_0000218 NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.